PHARMACOLOGY (HLTH 314) - EXAM 1 2025 UPDATED ACTUAL EXAM WITH
CORRECT SOLUTIONS.
Question 1
Which of the following terms describes the movement of a drug from its site of administration
into the bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
E) Bioavailability
Correct Answer: C) Absorption
Rationale: Absorption is the first phase of pharmacokinetics and involves the process of a
drug moving from the location it was administered (such as the GI tract, muscle, or skin)
into the systemic circulation. Factors affecting this include the route of administration,
drug solubility, and blood flow to the site.
Question 2
What is the term for the process by which the body chemically changes a drug into a form that
can be excreted?
A) Pharmacodynamics
B) Biotransformation
C) Passive diffusion
D) Distribution
E) First-pass effect
Correct Answer: B) Biotransformation
Rationale: Biotransformation, also known as metabolism, is the biochemical alteration of a
drug into an inactive metabolite, a more soluble compound, or a more potent active
metabolite. This occurs primarily in the liver through the action of specialized enzymes.
Question 3
Which organ is considered the primary site for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Intestines
E) Skin
Correct Answer: C) Kidneys
Rationale: While drugs can be excreted through bile, sweat, saliva, and breast milk, the
kidneys are the primary organs responsible for eliminating metabolic wastes and drugs
from the body through glomerular filtration, tubular reabsorption, and tubular secretion.
, 2
Question 4
A drug that is 95% protein-bound is administered to a patient with severely low albumin levels.
What is the most likely result?
A) The drug will be inactive.
B) The drug will have a decreased effect.
/C) There will be an increased risk of drug toxicity.
D) The drug will be excreted faster.
E) The drug will not be absorbed.
Correct Answer: C) There will be an increased risk of drug toxicity.
Rationale: Only "free" (unbound) drug molecules are pharmacologically active and able to
reach target tissues. If a patient has low albumin (hypoalbuminemia), there are fewer
binding sites available, leading to a higher concentration of free drug in the plasma, which
increases the risk of toxic effects.
Question 5
What is the "first-pass effect"?
A) The first time a patient receives a medication.
B) The time it takes for a drug to reach its maximum concentration.
C) The metabolism of an oral drug by the liver before it reaches systemic circulation.
D) The movement of a drug from the stomach into the small intestine.
E) The initial binding of a drug to a receptor site.
Correct Answer: C) The metabolism of an oral drug by the liver before it reaches systemic
circulation.
Rationale: Oral drugs are absorbed from the GI tract into the portal vein and travel
directly to the liver. Some drugs are extensively metabolized during this "first pass"
through the liver, significantly reducing the amount of active drug that reaches the rest of
the body. This is why some drugs must be given via non-oral routes (like IV or sublingual).
Question 6
Which route of administration provides the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
E) Transdermal
Correct Answer: D) Intravenous
Rationale: Intravenous (IV) administration bypasses the absorption process and the first-
pass effect entirely by depositing the drug directly into the bloodstream. Therefore, it
, 3
provides 100% bioavailability, allowing for rapid onset and precise control over blood
levels.
Question 7
What does the term "half-life" (t½) refer to in pharmacology?
A) The time required for half of the drug to be absorbed.
B) The time required for the amount of drug in the body to decrease by 50%.
C) The time it takes for a drug to begin working.
D) The duration of time a drug stays at the receptor site.
E) The shelf-life of a medication before it expires.
Correct Answer: B) The time required for the amount of drug in the body to decrease by
50%.
Rationale: Half-life is a measure of the rate at which a drug is eliminated from the body. It
is used to determine dosage intervals and the time required to reach steady-state
concentration. It generally takes about four to five half-lives for a drug to be considered
effectively removed from the system.
Question 8
Which of the following is an example of an "agonist"?
A) A drug that blocks a receptor.
B) A drug that has no effect on a cell.
C) A drug that binds to a receptor and produces a functional response.
D) A drug that prevents another drug from binding.
E) A drug that decreases the sensitivity of a receptor.
Correct Answer: C) A drug that binds to a receptor and produces a functional response.
Rationale: An agonist is a molecule that mimics the action of a naturally occurring
substance (like a neurotransmitter) by binding to a receptor and "turning it on," thereby
producing a biological response.
Question 9
A patient is prescribed a drug that has a narrow therapeutic index. What does this mean for the
nursing care?
A) The drug is very safe and requires little monitoring.
B) The drug is ineffective at low doses.
C) The difference between a therapeutic dose and a toxic dose is small.
D) The drug must be taken with food to be effective.
E) The drug has a very long half-life.
Correct Answer: C) The difference between a therapeutic dose and a toxic dose is small.
Rationale: The therapeutic index (TI) is a ratio that compares the blood concentration at
, 4
which a drug becomes toxic and the concentration at which it is effective. A narrow TI (low
ratio) means the drug is difficult to manage safely and requires frequent blood level
monitoring (Peak and Trough).
Question 10
Which of the following patient factors would most significantly decrease the rate of drug
metabolism?
A) Hypertension
B) Chronic Kidney Disease
C) Cirrhosis of the liver
D) Increased physical activity
E) A high-protein diet
Correct Answer: C) Cirrhosis of the liver
Rationale: Since the liver is the primary organ for drug metabolism via the P450 enzyme
system, any disease that damages liver tissue (like cirrhosis or hepatitis) will reduce
enzymatic activity, slowing the breakdown of drugs and leading to potential accumulation
and toxicity.
Question 11
The nurse is administering a medication that is classified as a "Schedule II" controlled substance.
What is a characteristic of this classification?
A) High potential for abuse, but currently accepted medical use.
B) No accepted medical use and high potential for abuse.
C) Low potential for abuse and limited psychological dependence.
D) Can be purchased over the counter without a prescription.
E) No risk of physical dependence.
Correct Answer: A) High potential for abuse, but currently accepted medical use.
Rationale: Schedule II drugs (e.g., morphine, oxycodone, fentanyl) have a high potential for
abuse which may lead to severe psychological or physical dependence, but they are
recognized as having therapeutic value. They have strict prescription requirements (no
refills).
Question 12
What is the primary goal of Phase 1 clinical trials in drug development?
A) To determine the drug's effectiveness in treating a specific disease.
B) To compare the new drug to existing treatments on the market.
C) To evaluate the drug's safety, dosage range, and pharmacokinetics in healthy volunteers.
D) To observe long-term adverse effects in the general population.
E) To test the drug on animals for genetic mutations.
CORRECT SOLUTIONS.
Question 1
Which of the following terms describes the movement of a drug from its site of administration
into the bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
E) Bioavailability
Correct Answer: C) Absorption
Rationale: Absorption is the first phase of pharmacokinetics and involves the process of a
drug moving from the location it was administered (such as the GI tract, muscle, or skin)
into the systemic circulation. Factors affecting this include the route of administration,
drug solubility, and blood flow to the site.
Question 2
What is the term for the process by which the body chemically changes a drug into a form that
can be excreted?
A) Pharmacodynamics
B) Biotransformation
C) Passive diffusion
D) Distribution
E) First-pass effect
Correct Answer: B) Biotransformation
Rationale: Biotransformation, also known as metabolism, is the biochemical alteration of a
drug into an inactive metabolite, a more soluble compound, or a more potent active
metabolite. This occurs primarily in the liver through the action of specialized enzymes.
Question 3
Which organ is considered the primary site for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Intestines
E) Skin
Correct Answer: C) Kidneys
Rationale: While drugs can be excreted through bile, sweat, saliva, and breast milk, the
kidneys are the primary organs responsible for eliminating metabolic wastes and drugs
from the body through glomerular filtration, tubular reabsorption, and tubular secretion.
, 2
Question 4
A drug that is 95% protein-bound is administered to a patient with severely low albumin levels.
What is the most likely result?
A) The drug will be inactive.
B) The drug will have a decreased effect.
/C) There will be an increased risk of drug toxicity.
D) The drug will be excreted faster.
E) The drug will not be absorbed.
Correct Answer: C) There will be an increased risk of drug toxicity.
Rationale: Only "free" (unbound) drug molecules are pharmacologically active and able to
reach target tissues. If a patient has low albumin (hypoalbuminemia), there are fewer
binding sites available, leading to a higher concentration of free drug in the plasma, which
increases the risk of toxic effects.
Question 5
What is the "first-pass effect"?
A) The first time a patient receives a medication.
B) The time it takes for a drug to reach its maximum concentration.
C) The metabolism of an oral drug by the liver before it reaches systemic circulation.
D) The movement of a drug from the stomach into the small intestine.
E) The initial binding of a drug to a receptor site.
Correct Answer: C) The metabolism of an oral drug by the liver before it reaches systemic
circulation.
Rationale: Oral drugs are absorbed from the GI tract into the portal vein and travel
directly to the liver. Some drugs are extensively metabolized during this "first pass"
through the liver, significantly reducing the amount of active drug that reaches the rest of
the body. This is why some drugs must be given via non-oral routes (like IV or sublingual).
Question 6
Which route of administration provides the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
E) Transdermal
Correct Answer: D) Intravenous
Rationale: Intravenous (IV) administration bypasses the absorption process and the first-
pass effect entirely by depositing the drug directly into the bloodstream. Therefore, it
, 3
provides 100% bioavailability, allowing for rapid onset and precise control over blood
levels.
Question 7
What does the term "half-life" (t½) refer to in pharmacology?
A) The time required for half of the drug to be absorbed.
B) The time required for the amount of drug in the body to decrease by 50%.
C) The time it takes for a drug to begin working.
D) The duration of time a drug stays at the receptor site.
E) The shelf-life of a medication before it expires.
Correct Answer: B) The time required for the amount of drug in the body to decrease by
50%.
Rationale: Half-life is a measure of the rate at which a drug is eliminated from the body. It
is used to determine dosage intervals and the time required to reach steady-state
concentration. It generally takes about four to five half-lives for a drug to be considered
effectively removed from the system.
Question 8
Which of the following is an example of an "agonist"?
A) A drug that blocks a receptor.
B) A drug that has no effect on a cell.
C) A drug that binds to a receptor and produces a functional response.
D) A drug that prevents another drug from binding.
E) A drug that decreases the sensitivity of a receptor.
Correct Answer: C) A drug that binds to a receptor and produces a functional response.
Rationale: An agonist is a molecule that mimics the action of a naturally occurring
substance (like a neurotransmitter) by binding to a receptor and "turning it on," thereby
producing a biological response.
Question 9
A patient is prescribed a drug that has a narrow therapeutic index. What does this mean for the
nursing care?
A) The drug is very safe and requires little monitoring.
B) The drug is ineffective at low doses.
C) The difference between a therapeutic dose and a toxic dose is small.
D) The drug must be taken with food to be effective.
E) The drug has a very long half-life.
Correct Answer: C) The difference between a therapeutic dose and a toxic dose is small.
Rationale: The therapeutic index (TI) is a ratio that compares the blood concentration at
, 4
which a drug becomes toxic and the concentration at which it is effective. A narrow TI (low
ratio) means the drug is difficult to manage safely and requires frequent blood level
monitoring (Peak and Trough).
Question 10
Which of the following patient factors would most significantly decrease the rate of drug
metabolism?
A) Hypertension
B) Chronic Kidney Disease
C) Cirrhosis of the liver
D) Increased physical activity
E) A high-protein diet
Correct Answer: C) Cirrhosis of the liver
Rationale: Since the liver is the primary organ for drug metabolism via the P450 enzyme
system, any disease that damages liver tissue (like cirrhosis or hepatitis) will reduce
enzymatic activity, slowing the breakdown of drugs and leading to potential accumulation
and toxicity.
Question 11
The nurse is administering a medication that is classified as a "Schedule II" controlled substance.
What is a characteristic of this classification?
A) High potential for abuse, but currently accepted medical use.
B) No accepted medical use and high potential for abuse.
C) Low potential for abuse and limited psychological dependence.
D) Can be purchased over the counter without a prescription.
E) No risk of physical dependence.
Correct Answer: A) High potential for abuse, but currently accepted medical use.
Rationale: Schedule II drugs (e.g., morphine, oxycodone, fentanyl) have a high potential for
abuse which may lead to severe psychological or physical dependence, but they are
recognized as having therapeutic value. They have strict prescription requirements (no
refills).
Question 12
What is the primary goal of Phase 1 clinical trials in drug development?
A) To determine the drug's effectiveness in treating a specific disease.
B) To compare the new drug to existing treatments on the market.
C) To evaluate the drug's safety, dosage range, and pharmacokinetics in healthy volunteers.
D) To observe long-term adverse effects in the general population.
E) To test the drug on animals for genetic mutations.
